B Group, Inc. Diversified Active

CIK: 0002043476 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $129,935 (100.0% shares, 0.0% debt)

Holdings (17)

ADMA ADMA BIOLOGICS INC 32.5%
Value ($000) $42,202 Shares 2,317,542 Est. Cost $18.79 Unrealized +8.5%
INSM INSMED INC 12.0%
Value ($000) $15,599 Shares 155,000 Est. Cost $72.02 Unrealized +6.2%
ZLAB ZAI LAB LTD 10.8%
Value ($000) $13,988 Shares 400,000 Est. Cost $26.19 Unrealized
AKERO THERAPEUTICS INC 9.5%
Value ($000) $12,403 Shares 232,446 Est. Cost $27.82 Unrealized
ELI LILLY & CO 9.0%
Value ($000) $11,693 Shares 15,000 Est. Cost Unrealized
CLLS CELLECTIS S A 3.8%
Value ($000) $4,966 Shares 3,256,501 Est. Cost $1.77 Unrealized
TSHA TAYSHA GENE THERAPIES INC 3.2%
Value ($000) $4,159 Shares 1,800,556 Est. Cost $2.04 Unrealized +6.5%
RARE ULTRAGENYX PHARMACEUTICAL IN 3.1%
Value ($000) $4,000 Shares 110,000 Est. Cost $39.00 Unrealized -7.6%
SGHT SIGHT SCIENCES INC 3.0%
Value ($000) $3,841 Shares 930,000 Est. Cost $4.05 Unrealized -17.5%
AURA AURA BIOSCIENCES INC 2.8%
Value ($000) $3,584 Shares 572,576 Est. Cost $8.79 Unrealized -33.5%
ASMB ASSEMBLY BIOSCIENCES INC 2.6%
Value ($000) $3,431 Shares 189,350 Est. Cost $13.84 Unrealized -4.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 2.0%
Value ($000) $2,580 Shares 1,500,000 Est. Cost $7.88 Unrealized -68.4%
ULTRAGENYX PHARMACEUTICAL IN 1.9%
Value ($000) $2,458 Shares 67,600 Est. Cost Unrealized
APGE APOGEE THERAPEUTICS INC 1.2%
Value ($000) $1,520 Shares 35,000 Est. Cost $43.86 Unrealized -13.3%
PRAX PRAXIS PRECISION MEDICINES I 1.1%
Value ($000) $1,472 Shares 35,000 Est. Cost $51.31 Unrealized -25.8%
SYRE SPYRE THERAPEUTICS INC 0.9%
Value ($000) $1,198 Shares 80,000 Est. Cost $25.38 Unrealized -41.7%
ORKA ORUKA THERAPEUTICS INC 0.6%
Value ($000) $841 Shares 75,000 Est. Cost $15.19 Unrealized -31.4%